back to events
Clarification sought regarding USFDA quality concerns
regulatory_filingNegative
confidence: 95%
Description
NSE has requested a formal clarification from Aurobindo Pharma Limited following a news report indicating that shares fell due to quality concerns flagged by the USFDA at the company's Telangana plant.